Erik Boot

Developmental trajectories in 22q11.2 deletion syndrome

Comparative mapping of the 22q11.2 deletion region and the potential of simple model organisms

Cognitive phenotype and psychiatric disorder in 22q11.2 deletion syndrome: A review

Implications of COMT long-range interactions on the phenotypic variability of 22q11.2 deletion syndrome

A pilot randomized trial of a cognitive reappraisal obesity prevention program

The predictive value of numerical magnitude comparison for individual differences in mathematics achievement

Modeling a model: Mouse genetics, 22q11.2 Deletion Syndrome, and disorders of cortical circuit development

22q11.21 Deletion Syndromes: A Review of Proximal, Central, and Distal Deletions and Their Associated Features

Chromosome 22q11.2 Deletion Syndrome (DiGeorge Syndrome/Velocardiofacial Syndrome)

Is there a core neuropsychiatric phenotype in 22q11.2 deletion syndrome?

Fetal growth and gestational factors as predictors of schizophrenia in 22q11.2 deletion syndrome

A gene expression atlas of the central nervous system based on bacterial artificial chromosomes

Schizophrenia-like neurophysiological abnormalities in 22q11.2 deletion syndrome and their association to COMT and PRODH genotypes

Response to clozapine in a clinically identifiable subtype of schizophrenia

Meta-analysis of magnetic resonance imaging studies in chromosome 22q11.2 deletion syndrome (velocardiofacial syndrome)

Catechol-O-methyltransferase polymorphism modulates cognitive control in children with chromosome 22q11.2 deletion syndrome

The importance of understanding cognitive trajectories

22q11.2 deletion syndrome

Quadruplex DNA: sequence, topology and structure

Whole-Genome Sequencing Suggests Schizophrenia Risk Mechanisms in Humans with 22q11.2 Deletion Syndrome

Psychopathology in adults with 22q11 deletion syndrome and moderate and severe intellectual disability

AnFgf8mouse mutant phenocopies human 22q11 deletion syndrome

Interventions for preventing obesity in children

Neurodevelopmental Outcomes in Children With Congenital Heart Disease: Evaluation and Management

COMT Val¹⁵⁸met genotype and striatal D_2/3 receptor binding in adults with 22q11 deletion syndrome

Practical guidelines for managing adults with 22q11.2 deletion syndrome

White matter abnormalities in adults with 22q11 deletion syndrome with and without schizophrenia

Disrupted Dopaminergic Neurotransmission in 22q11 Deletion Syndrome

Proton Magnetic Resonance Spectroscopy in 22q11 Deletion Syndrome

Functional Gene-Expression Analysis Shows Involvement of Schizophrenia-Relevant Pathways in Patients with 22q11 Deletion Syndrome

Serotonergic, noradrenergic and dopaminergic markers are related to cognitive function in adults with 22q11 deletion syndrome

Lower striatal dopamine D2/3 receptor availability in obese compared with non-obese subjects

PRODH rs450046 and proline x COMT Val158Met interaction effects on intelligence and startle in adults with 22q11 deletion syndrome

Movement disorders and other motor abnormalities in adults with 22q11.2 deletion syndrome

Startle reactivity and prepulse inhibition of the acoustic startle response are modulated by catechol-O-methyl-transferase Val¹⁵⁸ Met polymorphism in adults with 22q11 deletion syndrome

Dopamine metabolism in adults with 22q11 deletion syndrome, with and without schizophrenia – relationship with COMT Val^108/158 Met polymorphism, gender and symptomatology